Clinical Trial Detail

NCT ID NCT02657928
Title Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal or Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Indications

fallopian tube carcinoma

ovarian carcinoma

peritoneal carcinoma

endometrial cancer

Therapies

Letrozole + Ribociclib

Age Groups: adult

Additional content available in CKB BOOST